Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology
Head and Neck Cancer
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
A Study of TNFerade ™ with Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients with Head and Neck Cancer
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients with Head and Neck Cancer
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
Cancer: Are you planning to receive radiation therapy for head and neck cancer?
Cancer: Adults with Head and Neck Cancer Wanted for a Research Study
Drug & Dependencies: Do You Use Tobacco? Have You Been Diagnosed With Head and Neck Cancer?
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
People with Head and Neck Squamous Cell Carcinoma are asked to participate in a research study being conducted by Long Island Jewish Medical Center.
A Phase III, Multicenter, Randomized,Double-Blind,Placebo-Controlled Study to Assess Efficacy and Safety of Cevimeline in the Treatment of Xerostomia Secondary to Radiation Therapy for Cancer in the Head and Neck Region
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Carcinoma Of The Head And Neck
Men and Women 18 years and older wanted for head and neck cancer study.
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
If the patient has incurable Head & Neck cancer and has failed at least one course of standard platinum based chemotherapy, he/she may be eligible for this clinical trial.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.
